R
Renyikun Yuan
Researcher at University of Macau
Publications - 11
Citations - 156
Renyikun Yuan is an academic researcher from University of Macau. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 2 publications receiving 83 citations.
Papers
More filters
Journal ArticleDOI
Natural products to prevent drug resistance in cancer chemotherapy: a review
TL;DR: A concise review of two strategies using natural products against drug resistance, including nonapoptotic cell death and drug‐efflux inhibition, are summarized.
Journal ArticleDOI
Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways
Renyikun Yuan,Qiumei Fan,X. Liang,Shan-Shu Han,Jia He,Qin-Qin Wang,Hongwei Gao,Yulin Feng,Shilin Yang +8 more
TL;DR: Wang et al. as discussed by the authors investigated the effect of Cucurbitacin B (CuB) on EMT in A549 cells and showed that CuB inhibited the lung cancer metastasis effectively through intratracheal administration.
Journal ArticleDOI
Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway
TL;DR: It is reported that hederasaponin C (HSC) exerted a therapeutic effect against ALI through the regulation of the PIP2/NF-κB/NLRP3 signaling pathway, suggesting that HSC is a potential therapeutic agent for the clinical treatment of ALI.
Journal ArticleDOI
2-Methoxy-6-Acetyl-7-Methyljuglone (MAM) Induces iNOS/NO-mediated DNA Damage Response through Activation of MAPKs Pathways.
TL;DR: Results suggested that MAM induced iNOS/NO activation and generation mediated by MAPKs pathways, which resulted in DNA damage.
Journal ArticleDOI
Ginsenoside Rb1 exerts therapeutic effects on ulcerative colitis through regulating the Nrf2/PIP2/NLRP3 inflammasome signaling pathway
Siyuan Li,Renyikun Yuan,Qiumei Fan,Chun-Dong Zhang,Shan-Shu Han,Jilang Li,Zhipeng Xu,Kaili Sun,Qiongming Xu,Chun Yao,Shilin Yang,Hong Ni Gao +11 more
TL;DR: Wang et al. as mentioned in this paper explored the effects and potential mechanisms of ginsenoside rb1 on UC and showed that GRb1 has therapeutic effects on UC in vitro and in vivo through regulating the Nrf2/PIP2/NLRP3 pathway.